Zevra Therapeutics (ZVRA) Assets (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Assets of $302.71 million for Q2 2026, up 18.1% from $256.28 million a year earlier and up 8.7% from the prior quarter.
Zevra Therapeutics (ZVRA) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Assets came in at $284.73 million, up 59.8% from FY2024.
- Annual Assets has increased for three consecutive years, with a five-year compound annual growth rate of 91.0% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Assets was $178.13 million in FY2024 (+3.4%), $172.33 million in FY2023 (+49.4%), $115.34 million in FY2022 (-13.2%) and $132.94 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Assets in data going back to Q4 2014.
- On a year-over-year basis, Assets has increased in each of the last 12 quarters, with growth averaging 39.1% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q2 2025, with growth of 77.5%; the weakest was Q1 2023, with a decline of 15.2%.
- According to Business Quant data, Assets for the three prior quarters was $278.58 million (Q1 2026), $284.73 million (Q4 2025) and $270.12 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Zevra Therapeutics | 672.94 Mn | -139.77 Mn | 38.18 Mn | 302.71 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 302.71 Mn |
| Mar 31, 2026 | 278.58 Mn |
| Dec 31, 2025 | 284.73 Mn |
| Sep 30, 2025 | 270.12 Mn |
| Jun 30, 2025 | 256.28 Mn |
| Mar 31, 2025 | 172.71 Mn |
| Dec 31, 2024 | 178.13 Mn |
| Sep 30, 2024 | 191.55 Mn |
| Jun 30, 2024 | 144.41 Mn |
| Mar 31, 2024 | 151.28 Mn |
| Dec 31, 2023 | 172.33 Mn |
| Sep 30, 2023 | 138.98 Mn |
| Jun 30, 2023 | 105.52 Mn |
| Mar 31, 2023 | 106.60 Mn |
| Dec 31, 2022 | 115.34 Mn |
| Sep 30, 2022 | 119.55 Mn |
| Jun 30, 2022 | 124.26 Mn |
| Mar 31, 2022 | 125.71 Mn |
| Dec 31, 2021 | 132.94 Mn |
| Sep 30, 2021 | 137.19 Mn |
Zevra Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ZVRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();